Deze publicatie is alleen beschikbaar in het Engels.

Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the ‘TRIPOD’ trials


J. H. Richardus, S. G. Withington, A.M. Anderson, R. P. Croft, P. G. Nicholls, W.H. van Brakel, W.C.S. Smith

Reactions in leprosy patients causing acute nerve function impairment (NFI) can often be treated successfully with corticosteriods. Treatment with corticosteriods in leprosy control programmes is increasingly being provided under field conditions, often by paramedical workers.